title: Tacrolimus nephrotoxicity after renal transplantation.
authors.affiliation: Department of Surgery, University of Pittsburgh Medical Center, Pennsylvania, USA.
authors.forename: S R
authors.initials: SR
authors.lastname: Katari
authors.forename: M
authors.initials: M
authors.lastname: Magnone
authors.forename: R
authors.initials: R
authors.lastname: Shapiro
authors.forename: M
authors.initials: M
authors.lastname: Jordan
authors.forename: V
authors.initials: V
authors.lastname: Scantlebury
authors.forename: C
authors.initials: C
authors.lastname: Vivas
authors.forename: H A
authors.initials: HA
authors.lastname: Gritsch
authors.forename: J
authors.initials: J
authors.lastname: McCauley
authors.forename: T
authors.initials: T
authors.lastname: Starzl
authors.forename: A J
authors.initials: AJ
authors.lastname: Demetris
authors.forename: P S
authors.initials: PS
authors.lastname: Randhawa
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D003404:Creatinine / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology* / Q000502:physiology; D011188:Potassium / Q000097:blood; D016559:Tacrolimus / Q000009:adverse effects*; D013997:Time Factors; D014202:Tremor
chemical_list: D001786:Blood Glucose; D007166:Immunosuppressive Agents; D003404:Creatinine; D011188:Potassium; D016559:Tacrolimus